Carl Icahn Buys J.C. Penney Company Inc., Time Warner Cable Inc., Forstar Re Group, Sells Rowan Companies Inc., Genzyme Corp., MeadWestvaco Corp.

Author's Avatar
Feb 22, 2008
Billionaire activities investor Carl Icahn likes to buys stocks that are out of favor. He likes it even more if the whole industry is out of favor. The recent shakeup in fiancial sector certainly gives him opportunities. These are his buys and sells during the fourth quarter.


Carl Icahn buys J.C. Penney Company Inc., Time Warner Cable Inc., Forestar Re Group, GUARANTY FIN GROUP, Perry Ellis International Inc., AMICUS THERAPEUTICS, INC., sells Acorda Therapeutics Inc., Genzyme Corp., Harrah's Entertainment Inc., MGI PHARMA Inc., MeadWestvaco Corp., Children's Place Retail Stores Inc., Rowan Companies Inc. during the 3-months ended 12/31/2007, according to the most recent filings of his investment company, Icahn Capital Management LP. Carl Icahn owns 31 stocks with a total value of $4.8 billion. These are the details of the buys and sells.





New Purchases: FOLD, FOR, GFG, JCP, PERY, TWC,


Added Positions: APC, BBI, BEAS, M, TIN,


Reduced Positions: CMZ,


Sold Out: ACOR, GENZ, HET, MOGN, MWV, PLCE, RDC,





For the details of Carl Icahn's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn


Added: BEA Systems Inc. (BEAS, Financial)


Carl Icahn added to his holdings in BEA Systems Inc. by 210.23%. His purchase prices were between $15.47 and $18.82, with an estimated average price of $16.6. The impact to his portfolio due to this purchase was 9.18%. His holdings were 41,456,016 shares as of 12/31/2007.


BEA Systems, Inc. provides enterprise application and service infrastructure software worldwide. It offers BEA Tuxedo Product Family, an application infrastructure platform for mission-critical transaction processing systems, BEA Systems Inc. has a market cap of $7.6 billion; its shares were traded at around $18.83 with a P/E ratio of 237.34 and P/S ratio of 5.13.


Added: Anadarko Petroleum Corp. (APC, Financial)


Carl Icahn added to his holdings in Anadarko Petroleum Corp. by 8.82%. His purchase prices were between $56.35 and $66.97, with an estimated average price of $59.6. The impact to his portfolio due to this purchase was 1.63%. His holdings were 14,775,468 shares as of 12/31/2007.


Anadarko Petroleum Corporation engages in the acquisition, exploration, and production of oil and gas primarily in the United States, the deepwater of the Gulf of Mexico, and Algeria. Anadarko Petroleum Corp. has a market cap of $28.55 billion; its shares were traded at around $60.53 with a P/E ratio of 7.57 and P/S ratio of 2.57. The dividend yield of Anadarko Petroleum Corp. stocks is 0.7%.


Added: Macy's Inc. (M, Financial)


Carl Icahn added to his holdings in Macy's Inc. by 28.58%. His purchase prices were between $25.48 and $32.9, with an estimated average price of $29.4. The impact to his portfolio due to this purchase was 0.62%. His holdings were 5,164,660 shares as of 12/31/2007.


Macy's, Inc., through its subsidiaries, operates department stores in the United States. Its retail stores sell a range of merchandise, including men's, women's, and children's apparel; and accessories, cosmetics, home furnishings, Macy's Inc. has a market cap of $10.67 billion; its shares were traded at around $24.51 with a P/E ratio of 13.34 and P/S ratio of 0.40. The dividend yield of Macy's Inc. stocks is 2.1%.


Added: TempleInland Inc. (TIN, Financial)


Carl Icahn added to his holdings in TempleInland Inc. by 32.58%. His purchase prices were between $17.6 and $32.74, with an estimated average price of $26.1. The impact to his portfolio due to this purchase was 0.37%. His holdings were 3,448,488 shares as of 12/31/2007.


Temple-Inland, Inc., through its subsidiaries, engages in corrugated packaging, forest products, real estate, and financial services businesses in the United States. TempleInland Inc. has a market cap of $1.65 billion; its shares were traded at around $15.74 with a P/E ratio of 1.29 and P/S ratio of 0.43. The dividend yield of TempleInland Inc. stocks is 6.6%.


Added: Blockbuster Inc. (BBI, Financial)


Carl Icahn added to his holdings in Blockbuster Inc. by 14.55%. His purchase prices were between $3.18 and $5.53, with an estimated average price of $4.2. The impact to his portfolio due to this purchase was 0.11%. His holdings were 10,523,840 shares as of 12/31/2007.


Blockbuster, Inc., together with its subsidiaries, operates and franchises entertainment-related stores in the United States and internationally. It offers prerecorded videos, as well as video games for in-store rental, sale and trade, Blockbuster Inc. has a market cap of $581.57 million; its shares were traded at around $3.06 with P/S ratio of 0.11.


New Purchase: J.C. Penney Company Inc. (JCP, Financial)


Carl Icahn initiated holdings in J.C. Penney Company Inc.. His purchase prices were between $41.07 and $61.94, with an estimated average price of $48.1. The impact to his portfolio due to this purchase was 3.8%. His holdings were 4,166,271 shares as of 12/31/2007.


J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., sells merchandise and services to customers through its department stores and catalog/Internet channels. J.C. Penney Company Inc. has a market cap of $10.65 billion; its shares were traded at around $46.39 with a P/E ratio of 9.40 and P/S ratio of 0.53. The dividend yield of J.C. Penney Company Inc. stocks is 1.9%.


New Purchase: Time Warner Cable Inc. (TWC, Financial)


Carl Icahn initiated holdings in Time Warner Cable Inc.. His purchase prices were between $24.66 and $33.03, with an estimated average price of $27.5. The impact to his portfolio due to this purchase was 2.69%. His holdings were 4,711,128 shares as of 12/31/2007.


Time Warner Cable Inc. owns and manages cable television operations, as well as develops and provides video, data, and voice services to residential and commercial customers in the United States. Time Warner Cable Inc. has a market cap of $25.5 billion; its shares were traded at around $26.58 with a P/E ratio of 22.72 and P/S ratio of 1.63.


New Purchase: Forestar Re Group (FOR, Financial)


Carl Icahn initiated holdings in Forestar Re Group. His purchase prices were between $22.6 and $24.25, with an estimated average price of $23.6. The impact to his portfolio due to this purchase was 0.56%. His holdings were 1,149,495 shares as of 12/31/2007.


Forestar Real Estate Group, Inc. engages in the real estate and natural resources businesses in the United States. The real estate business engages in the acquisition, entitlement, development, and sale of real estate primarily for single-family houses. Forestar Re Group has a market cap of $912.61 million; its shares were traded at around $27.37 with a P/E ratio of 37.42 and P/S ratio of 5.32.


New Purchase: GUARANTY FIN GROUP (GFG, Financial)


Carl Icahn initiated holdings in GUARANTY FIN GROUP. His purchase prices were between $14.5 and $18, with an estimated average price of $15.8. The impact to his portfolio due to this purchase was 0.38%. His holdings were 1,149,495 shares as of 12/31/2007.


Guaranty Financial Group, Inc., through its subsidiary, Guaranty Bank, provides commercial banking products and services to consumers and businesses in Texas and California. GUARANTY FIN GROUP has a market cap of $534.95 million; its shares were traded at around $15.97 with a P/E ratio of 6.87 and P/S ratio of 1.13.


New Purchase: Perry Ellis International Inc. (PERY, Financial)


Carl Icahn initiated holdings in Perry Ellis International Inc.. His purchase prices were between $15.18 and $24.03, with an estimated average price of $19. The impact to his portfolio due to this purchase was 0.07%. His holdings were 206,025 shares as of 12/31/2007.


Perry Ellis International, Inc. operates as an apparel company. It engages in designing, sourcing, marketing, and licensing apparel products in the United States and internationally. Perry Ellis International Inc. has a market cap of $257.06 million; its shares were traded at around $17.53 with a P/E ratio of 9.52 and P/S ratio of 0.29.


New Purchase: AMICUS THERAPEUTICS, INC. (FOLD, Financial)


Carl Icahn initiated holdings in AMICUS THERAPEUTICS, INC.. His purchase prices were between $10.49 and $17.96, with an estimated average price of $15.2. The impact to his portfolio due to this purchase was 0.04%. His holdings were 201,940 shares as of 12/31/2007.


Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diceases. AMICUS THERAPEUTICS, INC. has a market cap of $233.06 million; its shares were traded at around $9.64 with P/S ratio of 121.21.


Reduced: Compton Petroleum Corp. (CMZ, Financial)


Carl Icahn reduced to his holdings in Compton Petroleum Corp. by 72.37%. His sale prices were between $7.91 and $9.37, with an estimated average price of $8.6. The impact to his portfolio due to this sale was 0.1%. Carl Icahn still held 967,397 shares as of 12/31/2007.


Compton Petroleum Corporation engages in the exploration, development, and production of natural gas, natural gas liquids, and crude oil in the Western Canadian Sedimentary Basin. Compton Petroleum Corp. has a market cap of $1.34 billion; its shares were traded at around $10.35 with a P/E ratio of 20.43 and P/S ratio of 3.45.


Sold Out: Rowan Companies Inc. (RDC)


Carl Icahn sold out his holdings in Rowan Companies Inc.. His sale prices were between $35.3 and $39.96, with an estimated average price of $37.8. The impact to his portfolio due to this sale was less than 0.01%.


Rowan Companies, Inc. provides a range of onshore and offshore contract drilling services in the United States and internationally. The company's drilling operations are conducted primarily in the Gulf of Mexico, the Middle East, the North Sea, Rowan Companies Inc. has a market cap of $4.34 billion; its shares were traded at around $38.59 with a P/E ratio of 10.71 and P/S ratio of 2.37. The dividend yield of Rowan Companies Inc. stocks is 1.2%.


Sold Out: Children's Place Retail Stores Inc. (PLCE)


Carl Icahn sold out his holdings in Children's Place Retail Stores Inc.. His sale prices were between $22.52 and $29.95, with an estimated average price of $25.9. The impact to his portfolio due to this sale was less than 0.01%.


The Children's Place Retail Stores, Inc. operates as a specialty retailer of merchandise for children. It focuses on the retail of apparel and accessories for children from newborn to 10 years of age. Children's Place Retail Stores Inc. has a market cap of $605.80 million; its shares were traded at around $20.67 with a P/E ratio of 14.02 and P/S ratio of 0.28.


Sold Out: MeadWestvaco Corp. (MWV)


Carl Icahn sold out his holdings in MeadWestvaco Corp.. His sale prices were between $30.41 and $33.95, with an estimated average price of $31.7. The impact to his portfolio due to this sale was less than 0.01%.


MeadWestvaco Corporation operates in the packaging, consumer and office products, specialty chemicals, and specialty papers markets. The company operates four segments: Packaging Resources, Consumer Solutions, Consumer and Office Products, MeadWestvaco Corp. has a market cap of $4.7 billion; its shares were traded at around $25.85 with a P/E ratio of 16.82 and P/S ratio of 0.68. The dividend yield of MeadWestvaco Corp. stocks is 3.4%.


Sold Out: Genzyme Corp. (GENZ)


Carl Icahn sold out his holdings in Genzyme Corp.. His sale prices were between $68.89 and $76.45, with an estimated average price of $73.5. The impact to his portfolio due to this sale was less than 0.01%.


Genzyme Corporation operates as a biotechnology company in the United States, European Union, Latin America, and Asia Pacific. It operates through five segments: Renal, Therapeutics, Transplant, Biosurgery, and Genetics. Genzyme Corp. has a market cap of $18.97 billion; its shares were traded at around $72.56 with a P/E ratio of 41.14 and P/S ratio of 5.05.


Sold Out: Acorda Therapeutics Inc. (ACOR)


Carl Icahn sold out his holdings in Acorda Therapeutics Inc.. His sale prices were between $17.21 and $22.11, with an estimated average price of $19.6. The impact to his portfolio due to this sale was less than 0.01%.


Acorda Therapeutics, Inc., a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple sclerosis (MS), Acorda Therapeutics Inc. has a market cap of $667.04 million; its shares were traded at around $24.7 with P/S ratio of 17.84.